Healthy India - Cervavac: Breakthrough in Cervical Cancer | 21 December, 2022

Sansad TV
India will roll out the indigenously developed HPV vaccine against cervical cancer for girls in the age group of 9–14 under the National Immunisation Programme by mid-2023. Developed by the Serum Institute of India, the quadrivalent vaccine called ‘Cervavac’, has a relatively lower price tag of Rs 200-400. India is dependent on foreign manufacturers for the vaccine, currently priced between Rs 3000-4000. It’s being described as a major breakthrough as India accounts for about a quarter of all cervical cancer cases & nearly a third of global cervical cancer deaths.

Anchor: Teena Jha

1. Dr. Manoj Sharma, Consultant, Clinical Oncology, Delhi State Cancer Institute
2. Dr. Kanika Sylonia, Consultant, Gynecologist & Obstetrician RML Hospital

Follow us on:

Subscribe to Sansad TV YouTube Channel:

Visit Sansad TV website:

Related Episodes